Effect of vitamin-D analogue on albuminuria in patients with non-dialysed chronic kidney disease stage 4–5: a retrospective single center study

BACKGROUND: The vitamin D receptor activator paricalcitol has been shown to reduce albuminuria. Whether this is a unique property of paricalcitol, or common to all vitamin D analogues, is unknown. The primary aim of this study was to evaluate the effect of alfacalcidol on proteinuria, measured as 24...

Descripción completa

Detalles Bibliográficos
Autores principales: Jørgensen, Hanne Skou, Winther, Simon, Povlsen, Johan Vestergaard, Ivarsen, Per
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475058/
https://www.ncbi.nlm.nih.gov/pubmed/22958603
http://dx.doi.org/10.1186/1471-2369-13-102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475058/
https://www.ncbi.nlm.nih.gov/pubmed/22958603
http://dx.doi.org/10.1186/1471-2369-13-102

Ejemplares similares